- Home
- COSM
COSM
Cosmos Health Inc.
as 07-26-2024 4:00pm EST
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | THESSALONIKI |
| Market Cap: | 11.8M | IPO Year: | 2013 |
| Target Price: | N/A | AVG Volume (30 days): | 6.0M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.47 - $2.05 | Next Earning Date: | 08-13-2024 |
| Revenue: | $49,588,253 | Revenue Growth: | -8.97% |
| Revenue Growth (this year): | 3.9% | Revenue Growth (next year): | 24.76% |
Stock Insider Trading Activity of Cosmos Health Inc. (COSM)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Siokas Grigorios | COSM | Chief Executive Officer | Feb 16 '24 | Buy | $0.83 | 60,000 | $49,806.00 | 1,394,597 | SEC Form 4 |
Latest Cosmos Health Inc. News
COSM Breaking Stock News: Dive into COSM Ticker-Specific Updates for Smart Investing
ACCESSWIRE
a day ago
Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland
ACCESSWIRE
a day ago
Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar
ACCESSWIRE
2 days ago
Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity
ACCESSWIRE
7 days ago
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule
ACCESSWIRE
8 days ago
Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units
ACCESSWIRE
16 days ago
Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market
ACCESSWIRE
17 days ago
Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually
ACCESSWIRE
24 days ago
Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months
Compare COSM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COSM Cosmos Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.